Jones D B, Moore M
Br J Cancer. 1973 Jun;27(6):415-26. doi: 10.1038/bjc.1973.52.
FBJ osteosarcoma virus (FBJ-MSV) isolated originally from a spontaneously arising osteosarcoma in a CF1 mouse is the only known naturally occurring murine sarcoma virus (MSV). It is unique among strains of MSV in producing primarily sarcomata in mice. The capacity of tumour cells transformed in vivo by this agent to elicit specific transplantation immunity in syngeneic hosts was investigated. A low level of resistance (10(4)-10(5) cells) was consistently induced by implantation of x-irradiated (15,000 rad) tumours or surgical excision of developing subcutaneous grafts. By contrast intraperitoneal inoculation of virus containing cellfree extracts of FBJ-MSV sarcomata was a far less effective immunization procedure. Confirmatory evidence for the antigenicity of these neoplasms was obtained in tests in which preincubation of tumour cells with lymphoid cells from specifically immune donors inhibited in vivo outgrowth of the FBJ-MSV cells in untreated syngeneic recipients. The induction of host resistance to FBJ-MSV cells by immunization with identical and independently-induced FBJ-MSV tumours established that FBJ-MSV cells possess common cell surface antigenic specificities in a manner analogous to those of experimental neoplasms induced by other oncogenic DNA and RNA viruses. Since FBJ-MSV cells release infectious virus it was not possible in this system to establish whether the tumour-rejection antigen was cellular or virion in nature. The antigenic weakness of FBJ-MSV cells in syngeneic hosts is comparable with that of virus-induced murine leukaemias of the Gross (G) or "wild" type subgroup to which category FBJ-MSV also belongs. These features suggest that FBJ-MSV exemplifies naturally occurring sarcomagenic viruses more closely than those of the Friend-Moloney-Rauscher-Graffi (FMRGr) subgroup which in general induce highly antigenic neoplasms.
FBJ骨肉瘤病毒(FBJ-MSV)最初从一只CF1小鼠自发产生的骨肉瘤中分离出来,是唯一已知的自然发生的鼠肉瘤病毒(MSV)。在MSV毒株中,它独一无二,主要在小鼠体内诱发肉瘤。研究了这种因子在体内转化的肿瘤细胞在同基因宿主中引发特异性移植免疫的能力。植入经X射线照射(15000拉德)的肿瘤或手术切除正在生长的皮下移植物,可持续诱导出低水平的抵抗力(10⁴-10⁵个细胞)。相比之下,腹腔接种含有FBJ-MSV肉瘤无细胞提取物的病毒,免疫程序效果要差得多。在实验中,将肿瘤细胞与来自特异性免疫供体的淋巴细胞预先孵育,可抑制未处理的同基因受体中FBJ-MSV细胞在体内的生长,从而获得了这些肿瘤具有抗原性的确证。用相同的和独立诱导的FBJ-MSV肿瘤进行免疫,可诱导宿主对FBJ-MSV细胞产生抵抗力,这表明FBJ-MSV细胞具有共同的细胞表面抗原特异性,其方式类似于其他致癌DNA和RNA病毒诱导的实验性肿瘤。由于FBJ-MSV细胞释放传染性病毒,在这个系统中无法确定肿瘤排斥抗原本质上是细胞性的还是病毒体性的。FBJ-MSV细胞在同基因宿主中的抗原性较弱,与格罗斯(G)型或“野生”型亚组的病毒诱导的鼠白血病相当,FBJ-MSV也属于这一类别。这些特征表明,与一般诱导高抗原性肿瘤的弗瑞德-莫洛尼-劳斯彻-格拉菲(FMRGr)亚组的病毒相比,FBJ-MSV更能代表自然发生的致肉瘤病毒。